nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlormerodrin—SLC12A1—collecting duct of renal tubule—kidney cancer	0.188	0.353	CbGeAlD
Chlormerodrin—SLC12A1—nephron—kidney cancer	0.0835	0.157	CbGeAlD
Chlormerodrin—SLC12A1—urine—kidney cancer	0.067	0.126	CbGeAlD
Chlormerodrin—ALDH5A1—nephron tubule—kidney cancer	0.0242	0.0455	CbGeAlD
Chlormerodrin—ALDH5A1—renal system—kidney cancer	0.022	0.0414	CbGeAlD
Chlormerodrin—ALDH5A1—kidney—kidney cancer	0.0213	0.04	CbGeAlD
Chlormerodrin—ALDH5A1—Vinblastine—Vincristine—kidney cancer	0.021	1	CbGdCrCtD
Chlormerodrin—ALDH5A1—cortex of kidney—kidney cancer	0.0207	0.0389	CbGeAlD
Chlormerodrin—Venous thrombosis—Temsirolimus—kidney cancer	0.0205	0.0457	CcSEcCtD
Chlormerodrin—ALDH5A1—gonad—kidney cancer	0.0197	0.0371	CbGeAlD
Chlormerodrin—ALDH5A1—cardiac atrium—kidney cancer	0.0197	0.037	CbGeAlD
Chlormerodrin—SLC12A1—nephron tubule—kidney cancer	0.018	0.0339	CbGeAlD
Chlormerodrin—SLC12A1—renal system—kidney cancer	0.0164	0.0308	CbGeAlD
Chlormerodrin—SLC12A1—kidney—kidney cancer	0.0158	0.0298	CbGeAlD
Chlormerodrin—SLC12A1—cortex of kidney—kidney cancer	0.0154	0.029	CbGeAlD
Chlormerodrin—Abscess—Temsirolimus—kidney cancer	0.014	0.0312	CcSEcCtD
Chlormerodrin—Extravasation—Temsirolimus—kidney cancer	0.0127	0.0283	CcSEcCtD
Chlormerodrin—Extravasation—Vinblastine—kidney cancer	0.00945	0.0211	CcSEcCtD
Chlormerodrin—Tenderness—Erlotinib—kidney cancer	0.00909	0.0203	CcSEcCtD
Chlormerodrin—Abscess—Sunitinib—kidney cancer	0.00867	0.0194	CcSEcCtD
Chlormerodrin—Venous thrombosis—Paclitaxel—kidney cancer	0.00854	0.0191	CcSEcCtD
Chlormerodrin—Necrosis—Dactinomycin—kidney cancer	0.00828	0.0185	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Everolimus—kidney cancer	0.00807	0.018	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Temsirolimus—kidney cancer	0.00802	0.0179	CcSEcCtD
Chlormerodrin—Hyponatraemia—Pazopanib—kidney cancer	0.00758	0.0169	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Pazopanib—kidney cancer	0.00755	0.0169	CcSEcCtD
Chlormerodrin—Extravasation—Dactinomycin—kidney cancer	0.00745	0.0166	CcSEcCtD
Chlormerodrin—Venous thrombosis—Capecitabine—kidney cancer	0.00701	0.0157	CcSEcCtD
Chlormerodrin—Phlebitis—Vinblastine—kidney cancer	0.00695	0.0155	CcSEcCtD
Chlormerodrin—Ulcer—Dactinomycin—kidney cancer	0.00687	0.0153	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Sunitinib—kidney cancer	0.00674	0.0151	CcSEcCtD
Chlormerodrin—Extravasation—Vincristine—kidney cancer	0.00665	0.0149	CcSEcCtD
Chlormerodrin—Tenderness—Gemcitabine—kidney cancer	0.00631	0.0141	CcSEcCtD
Chlormerodrin—Extravasation—Gemcitabine—kidney cancer	0.00631	0.0141	CcSEcCtD
Chlormerodrin—Hyponatraemia—Everolimus—kidney cancer	0.00599	0.0134	CcSEcCtD
Chlormerodrin—Necrosis—Paclitaxel—kidney cancer	0.00587	0.0131	CcSEcCtD
Chlormerodrin—Ulcer—Gemcitabine—kidney cancer	0.00582	0.013	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Erlotinib—kidney cancer	0.00575	0.0129	CcSEcCtD
Chlormerodrin—Phlebitis—Dactinomycin—kidney cancer	0.00547	0.0122	CcSEcCtD
Chlormerodrin—Tenderness—Paclitaxel—kidney cancer	0.00528	0.0118	CcSEcCtD
Chlormerodrin—Extravasation—Paclitaxel—kidney cancer	0.00528	0.0118	CcSEcCtD
Chlormerodrin—Hyponatraemia—Sorafenib—kidney cancer	0.0052	0.0116	CcSEcCtD
Chlormerodrin—Hyponatraemia—Sunitinib—kidney cancer	0.005	0.0112	CcSEcCtD
Chlormerodrin—Venous thrombosis—Doxorubicin—kidney cancer	0.00452	0.0101	CcSEcCtD
Chlormerodrin—Flatulence—Pazopanib—kidney cancer	0.00448	0.01	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Sorafenib—kidney cancer	0.00429	0.00958	CcSEcCtD
Chlormerodrin—Hyponatraemia—Vincristine—kidney cancer	0.00423	0.00945	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Sunitinib—kidney cancer	0.00413	0.00922	CcSEcCtD
Chlormerodrin—Ulcer—Capecitabine—kidney cancer	0.004	0.00894	CcSEcCtD
Chlormerodrin—Infection—Temsirolimus—kidney cancer	0.00391	0.00875	CcSEcCtD
Chlormerodrin—Phlebitis—Paclitaxel—kidney cancer	0.00388	0.00868	CcSEcCtD
Chlormerodrin—Infection—Pazopanib—kidney cancer	0.00369	0.00824	CcSEcCtD
Chlormerodrin—Flatulence—Everolimus—kidney cancer	0.00354	0.00791	CcSEcCtD
Chlormerodrin—Flatulence—Erlotinib—kidney cancer	0.00341	0.00763	CcSEcCtD
Chlormerodrin—Hyponatraemia—Paclitaxel—kidney cancer	0.00336	0.00751	CcSEcCtD
Chlormerodrin—Phlebitis—Capecitabine—kidney cancer	0.00319	0.00712	CcSEcCtD
Chlormerodrin—Body temperature increased—Temsirolimus—kidney cancer	0.00311	0.00696	CcSEcCtD
Chlormerodrin—Necrosis—Doxorubicin—kidney cancer	0.00311	0.00694	CcSEcCtD
Chlormerodrin—Abscess—Doxorubicin—kidney cancer	0.00308	0.00689	CcSEcCtD
Chlormerodrin—Flatulence—Sunitinib—kidney cancer	0.00296	0.0066	CcSEcCtD
Chlormerodrin—Infection—Everolimus—kidney cancer	0.00291	0.00651	CcSEcCtD
Chlormerodrin—Infection—Erlotinib—kidney cancer	0.00281	0.00628	CcSEcCtD
Chlormerodrin—Extravasation—Doxorubicin—kidney cancer	0.00279	0.00624	CcSEcCtD
Chlormerodrin—Hyponatraemia—Capecitabine—kidney cancer	0.00276	0.00616	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.00275	0.00614	CcSEcCtD
Chlormerodrin—Diarrhoea—Temsirolimus—kidney cancer	0.0027	0.00602	CcSEcCtD
Chlormerodrin—Ulcer—Doxorubicin—kidney cancer	0.00258	0.00576	CcSEcCtD
Chlormerodrin—Diarrhoea—Pazopanib—kidney cancer	0.00254	0.00568	CcSEcCtD
Chlormerodrin—Infection—Sorafenib—kidney cancer	0.00253	0.00565	CcSEcCtD
Chlormerodrin—Vomiting—Temsirolimus—kidney cancer	0.00251	0.0056	CcSEcCtD
Chlormerodrin—Rash—Temsirolimus—kidney cancer	0.00248	0.00555	CcSEcCtD
Chlormerodrin—Dermatitis—Temsirolimus—kidney cancer	0.00248	0.00555	CcSEcCtD
Chlormerodrin—Infection—Sunitinib—kidney cancer	0.00243	0.00543	CcSEcCtD
Chlormerodrin—Hyperkalaemia—Doxorubicin—kidney cancer	0.0024	0.00535	CcSEcCtD
Chlormerodrin—Vomiting—Pazopanib—kidney cancer	0.00236	0.00527	CcSEcCtD
Chlormerodrin—Rash—Pazopanib—kidney cancer	0.00234	0.00523	CcSEcCtD
Chlormerodrin—Nausea—Temsirolimus—kidney cancer	0.00234	0.00523	CcSEcCtD
Chlormerodrin—Dermatitis—Pazopanib—kidney cancer	0.00234	0.00522	CcSEcCtD
Chlormerodrin—Body temperature increased—Everolimus—kidney cancer	0.00232	0.00518	CcSEcCtD
Chlormerodrin—Infection—Dactinomycin—kidney cancer	0.0023	0.00514	CcSEcCtD
Chlormerodrin—Abdominal discomfort—Capecitabine—kidney cancer	0.00228	0.00508	CcSEcCtD
Chlormerodrin—Body temperature increased—Erlotinib—kidney cancer	0.00224	0.005	CcSEcCtD
Chlormerodrin—Nausea—Pazopanib—kidney cancer	0.0022	0.00493	CcSEcCtD
Chlormerodrin—Infection—Vincristine—kidney cancer	0.00206	0.0046	CcSEcCtD
Chlormerodrin—Phlebitis—Doxorubicin—kidney cancer	0.00205	0.00459	CcSEcCtD
Chlormerodrin—Diarrhoea—Vinblastine—kidney cancer	0.00201	0.0045	CcSEcCtD
Chlormerodrin—Body temperature increased—Sorafenib—kidney cancer	0.00201	0.00449	CcSEcCtD
Chlormerodrin—Diarrhoea—Everolimus—kidney cancer	0.00201	0.00448	CcSEcCtD
Chlormerodrin—Flatulence—Paclitaxel—kidney cancer	0.00199	0.00444	CcSEcCtD
Chlormerodrin—Infection—Gemcitabine—kidney cancer	0.00195	0.00436	CcSEcCtD
Chlormerodrin—Body temperature increased—Sunitinib—kidney cancer	0.00194	0.00432	CcSEcCtD
Chlormerodrin—Diarrhoea—Erlotinib—kidney cancer	0.00193	0.00432	CcSEcCtD
Chlormerodrin—Vomiting—Vinblastine—kidney cancer	0.00187	0.00418	CcSEcCtD
Chlormerodrin—Vomiting—Everolimus—kidney cancer	0.00186	0.00416	CcSEcCtD
Chlormerodrin—Rash—Everolimus—kidney cancer	0.00185	0.00413	CcSEcCtD
Chlormerodrin—Dermatitis—Everolimus—kidney cancer	0.00185	0.00413	CcSEcCtD
Chlormerodrin—Body temperature increased—Dactinomycin—kidney cancer	0.00183	0.00409	CcSEcCtD
Chlormerodrin—Vomiting—Erlotinib—kidney cancer	0.0018	0.00402	CcSEcCtD
Chlormerodrin—Rash—Erlotinib—kidney cancer	0.00178	0.00398	CcSEcCtD
Chlormerodrin—Dermatitis—Erlotinib—kidney cancer	0.00178	0.00398	CcSEcCtD
Chlormerodrin—Hyponatraemia—Doxorubicin—kidney cancer	0.00178	0.00397	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00177	0.00396	CcSEcCtD
Chlormerodrin—Nausea—Vinblastine—kidney cancer	0.00175	0.00391	CcSEcCtD
Chlormerodrin—Nausea—Everolimus—kidney cancer	0.00174	0.00389	CcSEcCtD
Chlormerodrin—Diarrhoea—Sorafenib—kidney cancer	0.00174	0.00389	CcSEcCtD
Chlormerodrin—Nausea—Erlotinib—kidney cancer	0.00168	0.00375	CcSEcCtD
Chlormerodrin—Diarrhoea—Sunitinib—kidney cancer	0.00168	0.00374	CcSEcCtD
Chlormerodrin—Body temperature increased—Vincristine—kidney cancer	0.00164	0.00366	CcSEcCtD
Chlormerodrin—Infection—Paclitaxel—kidney cancer	0.00163	0.00365	CcSEcCtD
Chlormerodrin—Flatulence—Capecitabine—kidney cancer	0.00163	0.00364	CcSEcCtD
Chlormerodrin—Vomiting—Sorafenib—kidney cancer	0.00162	0.00361	CcSEcCtD
Chlormerodrin—Rash—Sorafenib—kidney cancer	0.0016	0.00358	CcSEcCtD
Chlormerodrin—Dermatitis—Sorafenib—kidney cancer	0.0016	0.00358	CcSEcCtD
Chlormerodrin—Diarrhoea—Dactinomycin—kidney cancer	0.00159	0.00354	CcSEcCtD
Chlormerodrin—Vomiting—Sunitinib—kidney cancer	0.00156	0.00348	CcSEcCtD
Chlormerodrin—Body temperature increased—Gemcitabine—kidney cancer	0.00155	0.00347	CcSEcCtD
Chlormerodrin—Rash—Sunitinib—kidney cancer	0.00154	0.00345	CcSEcCtD
Chlormerodrin—Dermatitis—Sunitinib—kidney cancer	0.00154	0.00345	CcSEcCtD
Chlormerodrin—Nausea—Sorafenib—kidney cancer	0.00151	0.00338	CcSEcCtD
Chlormerodrin—Vomiting—Dactinomycin—kidney cancer	0.00147	0.00329	CcSEcCtD
Chlormerodrin—Rash—Dactinomycin—kidney cancer	0.00146	0.00327	CcSEcCtD
Chlormerodrin—Nausea—Sunitinib—kidney cancer	0.00145	0.00325	CcSEcCtD
Chlormerodrin—Diarrhoea—Vincristine—kidney cancer	0.00142	0.00317	CcSEcCtD
Chlormerodrin—Nausea—Dactinomycin—kidney cancer	0.00138	0.00308	CcSEcCtD
Chlormerodrin—Diarrhoea—Gemcitabine—kidney cancer	0.00134	0.003	CcSEcCtD
Chlormerodrin—Infection—Capecitabine—kidney cancer	0.00134	0.003	CcSEcCtD
Chlormerodrin—Vomiting—Vincristine—kidney cancer	0.00132	0.00294	CcSEcCtD
Chlormerodrin—Rash—Vincristine—kidney cancer	0.00131	0.00292	CcSEcCtD
Chlormerodrin—Dermatitis—Vincristine—kidney cancer	0.0013	0.00291	CcSEcCtD
Chlormerodrin—Body temperature increased—Paclitaxel—kidney cancer	0.0013	0.00291	CcSEcCtD
Chlormerodrin—Vomiting—Gemcitabine—kidney cancer	0.00125	0.00279	CcSEcCtD
Chlormerodrin—Rash—Gemcitabine—kidney cancer	0.00124	0.00277	CcSEcCtD
Chlormerodrin—Dermatitis—Gemcitabine—kidney cancer	0.00124	0.00276	CcSEcCtD
Chlormerodrin—Nausea—Vincristine—kidney cancer	0.00123	0.00275	CcSEcCtD
Chlormerodrin—Nausea—Gemcitabine—kidney cancer	0.00117	0.00261	CcSEcCtD
Chlormerodrin—Diarrhoea—Paclitaxel—kidney cancer	0.00113	0.00251	CcSEcCtD
Chlormerodrin—Body temperature increased—Capecitabine—kidney cancer	0.00107	0.00238	CcSEcCtD
Chlormerodrin—Flatulence—Doxorubicin—kidney cancer	0.00105	0.00235	CcSEcCtD
Chlormerodrin—Vomiting—Paclitaxel—kidney cancer	0.00105	0.00234	CcSEcCtD
Chlormerodrin—Rash—Paclitaxel—kidney cancer	0.00104	0.00232	CcSEcCtD
Chlormerodrin—Dermatitis—Paclitaxel—kidney cancer	0.00104	0.00231	CcSEcCtD
Chlormerodrin—Nausea—Paclitaxel—kidney cancer	0.000977	0.00218	CcSEcCtD
Chlormerodrin—Diarrhoea—Capecitabine—kidney cancer	0.000923	0.00206	CcSEcCtD
Chlormerodrin—Infection—Doxorubicin—kidney cancer	0.000864	0.00193	CcSEcCtD
Chlormerodrin—Vomiting—Capecitabine—kidney cancer	0.000858	0.00192	CcSEcCtD
Chlormerodrin—Rash—Capecitabine—kidney cancer	0.000851	0.0019	CcSEcCtD
Chlormerodrin—Dermatitis—Capecitabine—kidney cancer	0.00085	0.0019	CcSEcCtD
Chlormerodrin—Nausea—Capecitabine—kidney cancer	0.000802	0.00179	CcSEcCtD
Chlormerodrin—Body temperature increased—Doxorubicin—kidney cancer	0.000688	0.00154	CcSEcCtD
Chlormerodrin—Diarrhoea—Doxorubicin—kidney cancer	0.000595	0.00133	CcSEcCtD
Chlormerodrin—Vomiting—Doxorubicin—kidney cancer	0.000553	0.00124	CcSEcCtD
Chlormerodrin—Rash—Doxorubicin—kidney cancer	0.000549	0.00123	CcSEcCtD
Chlormerodrin—Dermatitis—Doxorubicin—kidney cancer	0.000548	0.00122	CcSEcCtD
Chlormerodrin—Nausea—Doxorubicin—kidney cancer	0.000517	0.00115	CcSEcCtD
